Associate Professor of Medicine
Dr. Kevin Kelly, MD is a hematologist with clinical expertise in phase I investigational therapeutics and hematological malignancies, including lymphoma and multiple myeloma. His research focuses on understanding the mechanisms of resistance to chemotherapy in hematological malignancies and the use of novel agents to overcome this resistance, and he has published extensively in peer-reviewed journals. Through collaborations with a large team of scientists, he has translated preclinical discoveries into novel clinical trials including an investigator-initiated study of the phosphodiesterase 4B inhibitor, roflumilast, in B cell lymphoproliferative disorders.
years treating myeloma:
Number of Myeloma Patients Treated Annually:
Details & contact info
1441 Eastlake Avenue Lincoln Heights Boyle Heights
Los Angeles, CA, United States, 90089
Send a message to Kevin Kelly, MD